Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 2 August 2023, 21:38 HKT/SGT
Share:
Kingworld Medicines Expects 1H Profit Increased By 35%-40%
Demonstrating Strong Business Performance and Competitive Strengths

HONG KONG, Aug 2, 2023 - (ACN Newswire) - Kingworld Medicines Group ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading healthcare distribution company, announced a projected rise in profit for the first half of the fiscal year. Based on a preliminary assessment of the unaudited consolidated management accounts of the Group for the six months ending June 30, 2023, the Group anticipates a profit surge ranging from approximately 35% to 40% for the period, compared to the same period last year.

The Board attributes this profit increase to increased revenue and gross profit stemming from the distribution of imported branded pharmaceutical and healthcare products in China, with growth rates reaching approximately 30% to 35% and 15% to 20%, respectively. Additionally, the Group's share of profit from a joint venture saw a boost of approximately 55% to 60% compared to the same period last year. This surge is attributed to the market recovery after the COVID-19 pandemic control measures.

Kingworld Medicines is a company specializing in the distribution of imported branded pharmaceutical and healthcare products in China. The Group adeptly navigated post-pandemic market changes, propelling business expansion by leveraging its industry strengths.

Mr. Zhao Lisheng, Chairman of the Board of Kingworld Medicines Group, commented: "The Group's profit increase was mainly due to market recovery and the Group's employees' unremitting efforts, which adapted post-pandemic. The Group's strengths lie in its strong capabilities in distributing pharmaceutical and healthcare products and its acute insights into the market. Besides, the Group has achieved long-term steady growth by continuously improving efficiency and expanding its business."

Looking ahead, Kingworld Medicines Group will continue to focus on increasing market share, expanding business coverage, and improving efficiency to further enhance the company's profitability and market competitiveness.



Topic: Press release summary Sectors: Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
The Executive Centre Advances Digital Transformation in Real Estate with AI Agent Integration  
Mar 17, 2026 10:00 HKT/SGT
Zylo Ecosystem Announces the Launch of the ZYLO Token to Expand Its Digital Ecosystem  
Mar 17, 2026 08:00 HKT/SGT
FinHarbor Introduces Neobank Platform Designed to Go Live in Under 30 Days  
Mar 16, 2026 20:30 HKT/SGT
THERMAL-XR(R) Sales in the United States to Commence After GMG Receives U.S. EPA Approval  
Mar 16, 2026 19:59 HKT/SGT
Hitachi Energy Japan Recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category)  
Monday, March 16, 2026 3:20:00 PM
Bonus Savings Account: What It Is and How It Helps You Earn More Interest  
Mar 16, 2026 15:10 HKT/SGT
China Lilang Announces 2025 Annual Results  
Mar 16, 2026 13:15 HKT/SGT
Fujitsu Japan and Teikyo University Hospital launch joint proof of concept to build mechanism for data analysis and referred-patient management  
Monday, March 16, 2026 11:55:00 AM
Accelerated Technology Commercialization Drives High-Growth Performance, Qunabox Group Leads the AI Interactive Marketing Track  
Mar 16, 2026 10:55 HKT/SGT
FWD Group delivers record full year 2025 results with profitable growth, improved capital and cash flow generation  
Monday, March 16, 2026 9:25:00 AM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: